We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
- Authors
Nashan, B; Moore, R; Amlot, P; Schmidt, A G; Abeywickrama, K; Soulillou, J P
- Abstract
Currently available immunosuppressive regimens for cadaver-kidney recipients are far from ideal because acute-rejection episodes occur in about 30% to 50% of these patients. In the phase III study described here we assessed the ability of basiliximab, a chimeric interleukin (IL)-2 receptor monoclonal antibody, to prevent acute-rejection episodes in renal allograft recipients.
- Publication
Lancet (London, England), 1997, Vol 350, Issue 9086, p1193
- ISSN
0140-6736
- Publication type
Journal Article
- DOI
10.1016/s0140-6736(97)09278-7